Updated Safety Materials for Valproate Users The MHRA has published updated safety and educational materials to support healthcare professionals and patients in discussing the reproductive risks associated with valproate medicines. These resources implement regulatory measures announced in the November 2023 National Patient Safety Alert and the September 2024 Drug Safety Update. Key Points Valproate carries […]
MHRA Alert – Valproate: Two-Specialist Review Now Required for New Patients Under 55
Key Update on Valproate Initiation Requirements The Commission on Human Medicines (CHM) has clarified prescribing requirements for valproate, a medication used to treat epilepsy and other conditions. Two specialist reviews are now mandatory for all patients under 55 years of age initiating valproate, regardless of sex or gender. Important Clarification for Existing Male Patients Male […]